Interleukin-10 but not interleukin-18 may be associated with the immune response against well differentiated thyroid cancer

Clinics

Volumn 66, Issue 7, 2011, Pages 1203-1208

  Cunha, Lucas Leite ^a   Tincani, Alfio José ^a   Assumpção, Ligia Vera Montalli da ^a   Soares, Fernando Augusto ^b   Vassallo, José ^a   Ward, Laura Sterian ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Chronic lymphocytic thyroiditis; Immunogenetics; Interleukin 10; Interleukin 18; Tumor immunity

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 18;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; ARTICLE; CARCINOMA; CASE CONTROL STUDY; CHILD; FEMALE; GENETICS; HASHIMOTO DISEASE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; THYROID TUMOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-18; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; THYROID NEOPLASMS; YOUNG ADULT;

EID: 80052166122     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000700014     Document Type: Article

References (35)

1. Pisanu A, Piu S, Cois A, Uccheddu A. Coexisting Hashimoto's thyroiditis with differentiated thyroid cancer and benign thyroid diseases: indications for thyroidectomy. Chir Ital. 2003;55:365-72.
2. Segal K, Ben-Bassat M, Avraham A, Har-El G, Sidi J. Hashimoto's thyroiditis and carcinoma of the thyroid gland. Int Surg. 1985;70:205-9.
3. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 1999;84:458-63. doi: 10.1210/jc.84.2.458.
4. Ugolini C, Basolo F, Proietti A, Vitti P, Elisei R, Miccoli P, et al. Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma. Thyroid. 2007;17: 389-93. doi: 10.1089/thy.2006.0306.
5. Arif S, Blanes A, Diaz-Cano SJ. Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology. 2002;41:357-62. doi: 10.1046/j.1365-2559.2002.01467.x.
6. Gasbarri A, Sciacchitano S, Marasco A, Papotti M, Di Napoli A, Marzullo A, et al. Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. Br J Cancer. 2004;1: 1096-104.
7. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420: 860-7. doi: 10.1038/nature01322.
8. Borrello MG, Alberti L, Fischer A, Degl'innocenti D, Ferrario C, Gariboldi M, et al. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad Sci U S A. 2005;102: 14825-30. doi: 10.1073/pnas.0503039102.
9. Guarino V, Castellone MD, Avilla E, Melillo RM. Thyroid cancer and inflammation. Mol Cell Endocrinol. 2009;321:94-102. doi: 10.1016/j.mce. 2009.10.003.
10. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88-91. doi: 10.1038/378088a0.
11. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996;26:1647-51. doi: 10. 1002/eji.1830260736
12. Boniotto M, Segat L, Milanese M, Crovella S. Detection of two functional polymorphisms in the promoter region of the IL-18 gene by single-tube allele specific PCR and melting temperature analysis. J Immunol Methods. 2005;304:184-8. doi: 10.1016/j.jim.2005.06.016
13. Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, Ogata A, et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun. 2006;342:1413-6. doi: 10.1016/j.bbrc. 2006.02.096
14. de la Vega JR, Vilaplana JC, Biro A, Hammond L, Bottazzo GF, Mirakian R. IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? Clin Exp Immunol. 1998;113:126-35. doi: 10.1046/ j.1365-2249.1998.00628.x
15. Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity. 2008;28: 468-76. doi: 10.1016/j.immuni.2008.03.003
16. Todaro M, Zerilli M, Ricci-Vitiani L, BiniM, Perez Alea M, Maria Florena A, et al. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res. 2006;66:1491-9. doi: 10.1158/0008-5472.CAN-05-2514
17. Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. 1998; 352:113. doi: 10.1016/S0140-6736(98)85018-6
18. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-214. doi: 10.1089/thy.2009.0110
19. Pitoia F, Ward L, Wohllk N, Friguglietti C, Tomimori E, Gauna A, et al. Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. Arq Bras Endocrinol Metabol. 2009;53:884-7. doi: 10.1590/S0004-27302009000700014
20. Wogensen L, Huang X, Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med. 1993;178:175-85. doi: 10.1084/jem.178.1.175
21. Erdogan M, Karadeniz M, Ozbek M, Ozgen AG, Berdeli A. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population. J Endocrinol Invest. 2008;31:750-4.
22. Zabaleta J, Lin HY, Sierra RA, Hall MC, Clark PE, Sartor OA, et al. Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis. 2008;29:573-8. doi: 10.1093/carcin/bgm277
23. Yao JG, Gao LB, Liu YG, Li J, Pang GF. Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta. 2008;388:84-8. doi: 10. 1016/j.cca.2007.10.012
24. Bogunia-Kubik K, Mazur G, Wrobel T, Kuliczkowski K, Lange A. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma. Tissue Antigens. 2008;71:146-50. doi: 10.1111/j. 1399-0039.2007.00984.x
25. Souza SL, Montalli Da Assumpcao LV, Ward LS. Impact of previous thyroid autoimmune diseases on prognosis of patients with welldifferentiated thyroid cancer. Thyroid. 2003;13:491-5. doi: 10.1089/ 105072503322021160
26. Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, et al. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2009;71: 581-6. doi: 10.1111/j.1365-2265.2009.03537.x
27. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, et al. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab. 2001;86:1346-54. doi: 10.1210/jc. 86.3.1346
28. Schaffler A, Palitzsch KD, Seiffarth C, Hohne HM, Riedhammer FJ, Hofstadter F, et al. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest. 1998; 28: 838-44. doi: 10. 1046/j.1365-2362.1998.00363.x
29. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 1999;126:1070-6. doi: 10.1067/msy.2099.101431
30. Ramos AM, Sales Ade O, Barbalho de Mello LE, Cirino de Andrade M, Pinto Paiva F, Ramos CC, et al. Absence of peritumoral fibrosis or inflammatory infiltrate may be related to clinical progression of papillary thyroid microcarcinoma. Int J Surg Pathol. 2009;17:432-7. doi: 10.1177/ 1066896909333749
31. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves' disease. World J Surg. 1990;14:437-40. doi: 10.1007/ BF01658550
32. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R. Outcome of differentiated thyroid cancer in Graves' patients. J Clin Endocrinol Metab. 1998;83:2805-9. doi: 10.1210/jc.83.8.2805
33. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, et al. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab. 1995;80:3421-4. doi: 10.1210/jc.80.12.3421
34. Yano Y, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K, et al. Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol. 2007;157:325-9. doi: 10.1530/EJE-07-0136
35. Kebebew E, Treseler PA, Ituarte PH, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. 2001;25:632-7. doi: 10.1007/s002680020165